Intracardiac Fibrinolysis and Endothelium Activation Related to Atrial Fibrillation Ablation with Different Techniques (scientific article published on 12 February 2020)

Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: Results from a multicenter study

Q30316734

Intracardiac Hemostasis and Fibrinolysis Parameters in Patients with Atrial Fibrillation

Q33872912

Effects of radiofrequency catheter ablation of atrial fibrillation on soluble P-selectin, von Willebrand factor and IL-6 in the peripheral and cardiac circulation

Q34497358

Biomarkers of myocardial injury with different energy sources for atrial fibrillation catheter ablation.

Q35057284

Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation

Q35868819

Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) P

Q38432008

Evaluation and reduction of asymptomatic cerebral embolism in ablation of atrial fibrillation, but high prevalence of chronic silent infarction: results of the evaluation of reduction of asymptomatic cerebral embolism trial

Q38445563

Cerebrovascular Complications Related to Atrial Fibrillation Ablation and Strategies for Periprocedural Stroke Prevention

Q38804142

Atrial Fibrillation Ablation and Stroke.

Q38826761

Uninterrupted Dabigatran versus Warfarin for Ablation in Atrial Fibrillation

Q38894950

Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation

Q39150012

Low rate of asymptomatic cerebral embolism and improved procedural efficiency with the novel pulmonary vein ablation catheter GOLD: results of the PRECISION GOLD trial

Q40941249

Cellular damage, platelet activation, and inflammatory response after pulmonary vein isolation: a randomized study comparing radiofrequency ablation with cryoablation

Q42616424

Microembolism and catheter ablation I: a comparison of irrigated radiofrequency and multielectrode-phased radiofrequency catheter ablation of pulmonary vein ostia

Q44972494

Incidence of silent cerebral thromboembolic lesions after atrial fibrillation ablation may change according to technology used: comparison of irrigated radiofrequency, multipolar nonirrigated catheter and cryoballoon

Q45040348

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation

Q45059153

Low risk of major complications associated with pulmonary vein antral isolation for atrial fibrillation: results of 500 consecutive ablation procedures in patients with low prevalence of structural heart disease from a single center

Q45761864

Endothelial damage and activation of the hemostatic system during radiofrequency catheter isolation of pulmonary veins

Q47631958

Transcranial measurement of cerebral microembolic signals during pulmonary vein isolation: a comparison of two ablation techniques.

Q51251310

Complications arising from catheter ablation of atrial fibrillation: temporal trends and predictors.

Q51433465

Delayed thrombogenesis following radiofrequency catheter ablation.

Q54541544

Does radiofrequency ablation induce a prethrombotic state? Analysis of coagulation system activation and comparison to electrophysiologic study.

Q64934433

Cerebral microembolization during atrial fibrillation ablation: comparison of different single-shot ablation techniques.

Q64967661

Thrombogenicity of radiofrequency ablation procedures: what factors influence thrombin generation?

Q74248025

Plasma von Willebrand factor and soluble p-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors

Q78346363

Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation

Q80111732

[The activation of haemostasis during radiofrequency catheter ablation]

Q81413625

Hemostatic changes before and during electrophysiologic study and radiofrequency catheter ablation

Q83567856

Transcranial measurement of cerebral microembolic signals during endocardial pulmonary vein isolation: comparison of three different ablation techniques

Q84112923

Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation: comparison of different atrial fibrillation ablation technologies in a multicenter study

Q84335035

Cryoballoon versus radiofrequency catheter ablation of paroxysmal atrial fibrillation: biomarkers of myocardial injury, recurrence rates, and pulmonary vein reconnection patterns

Q84980077

The Biophysics of Passive Convective Cooling During Catheter Ablation with Gold versus Platinum Electrodes and Multielectrode Phased Radiofrequency Energy Delivery

Q85605152

Does the number of simultaneously activated electrodes during phased RF multielectrode ablation of atrial fibrillation influence the incidence of silent cerebral microembolism?

Q86560012

Does periprocedural anticoagulation management of atrial fibrillation affect the prevalence of silent thromboembolic lesion detected by diffusion cerebral magnetic resonance imaging in patients undergoing radiofrequency atrial fibrillation ablation

Q87414934

P275

Creative Commons Attribution 4.0 International

copyrighted

main subject

Atrial Fibrillation

Q815819

P304